Lightwave Logic, Kyverna Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Dec 16, 2025, 8:26 AM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
KYTX's stock decline follows a significant capital raise announcement, which traditionally pressures prices down. Similar past incidents show stocks typically underperform post-offering announcements.
AI summary
What happened, with direct paths to the underlying reporting
Kyverna Therapeutics Inc (KYTX) fell 7.2% to $10.04 in pre-market trading. The decline followed KYTX's announcement of a $100 million offering. Other stocks like Lightwave Logic also experienced significant pre-market drops. Market sentiment appears bearish, influencing multiple biotech stocks today. Overall market futures are lower, impacting investor confidence.
Kyverna Therapeutics Inc (KYTX) fell 7.2% to $10.04 in pre-market trading.
The decline followed KYTX's announcement of a $100 million offering.
Other stocks like Lightwave Logic also experienced significant pre-market drops.
Overall market futures are lower, impacting investor confidence.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Kyverna Therapeutics focuses on cell therapies for autoimmune diseases, advancing KYV-101. KYV-101 trials aim for FDA approval for stiff person syndrome and myasthenia gravis. Kyv…